Which companies discussed AI Inference Demand in Health Care in earnings calls?

96 companies mentioned ai inference demand across 119 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Exelixis, Inc. (6 calls), Revolution Medicines, Inc. (6 calls), GeneDx Holdings Corp. (3 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning AI Inference Demand
2025Q321
2025Q426
2026Q134
2026Q238

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Exelixis, Inc. EXEL Health Care 6 Jun 9, 2026
Revolution Medicines, Inc. RVMD Health Care 6 May 31, 2026
GeneDx Holdings Corp. WGS Health Care 3 May 4, 2026
Moderna, Inc. MRNA Health Care 2 Jun 1, 2026
Summit Therapeutics Inc. SMMT Health Care 2 Jun 1, 2026
Protara Therapeutics, Inc. TARA Health Care 2 May 19, 2026
Alignment Healthcare, Inc. ALHC Health Care 2 May 13, 2026
Astrana Health, Inc. ASTH Health Care 2 May 7, 2026
Alnylam Pharmaceuticals, Inc. ALNY Health Care 2 Apr 30, 2026
Ocular Therapeutix, Inc. OCUL Health Care 2 Mar 2, 2026
Denali Therapeutics Inc. DNLI Health Care 2 Feb 5, 2026
Absci Corporation ABSI Health Care 2 Jan 14, 2026
Vera Therapeutics, Inc. VERA Health Care 2 Jan 13, 2026
Arcellx, Inc. ACLX Health Care 2 Dec 7, 2025
Enliven Therapeutics, Inc. ELVN Health Care 1 Jun 11, 2026
Maze Therapeutics, Inc. MAZE Health Care 1 Jun 10, 2026
Spectral Medical Inc. EDT Health Care 1 Jun 8, 2026
QMS Medical Allied Services Limited QMSMEDI Health Care 1 Jun 4, 2026
Poly Medicure Limited 531768 Health Care 1 May 25, 2026
Twist Bioscience Corporation TWST Health Care 1 May 21, 2026
ZIM Laboratories Limited 541400 Health Care 1 May 20, 2026
dorsaVi Ltd DVL Health Care 1 May 20, 2026
Design Therapeutics, Inc. DSGN Health Care 1 May 18, 2026
Axe Compute Inc. AGPU Health Care 1 May 18, 2026
Lucid Diagnostics Inc. LUCD Health Care 1 May 14, 2026
Invivyd, Inc. IVVD Health Care 1 May 14, 2026
Humacyte, Inc. HUMA Health Care 1 May 13, 2026
CeriBell, Inc. CBLL Health Care 1 May 13, 2026
Thyrocare Technologies Limited 539871 Health Care 1 May 12, 2026
10x Genomics, Inc. TXG Health Care 1 May 7, 2026
Harmony Biosciences Holdings, Inc. HRMY Health Care 1 May 7, 2026
Lantheus Holdings, Inc. LNTH Health Care 1 May 7, 2026
agilon health, inc. AGL Health Care 1 May 6, 2026
Viridian Therapeutics, Inc. VRDN Health Care 1 May 5, 2026
Cytokinetics, Incorporated CYTK Health Care 1 May 5, 2026
Alphatec Holdings, Inc. ATEC Health Care 1 May 5, 2026
iRhythm Holdings, Inc. IRTC Health Care 1 Apr 30, 2026
Pulse Biosciences, Inc. PLSE Health Care 1 Apr 25, 2026
Roche Holding AG ROP Health Care 1 Apr 22, 2026
Lantern Pharma Inc. LTRN Health Care 1 Apr 9, 2026
LENSAR, Inc. LNSR Health Care 1 Mar 31, 2026
Diamyd Medical AB (publ) DMYDB Health Care 1 Mar 30, 2026
Beam Therapeutics Inc. BEAM Health Care 1 Mar 25, 2026
MeiraGTx Holdings plc MGTX Health Care 1 Mar 25, 2026
Lineage Cell Therapeutics, Inc. LCTX Health Care 1 Mar 5, 2026
Galderma Group AG GALD Health Care 1 Mar 5, 2026
Ocugen, Inc. OCGN Health Care 1 Mar 4, 2026
Surgery Partners, Inc. SGRY Health Care 1 Mar 3, 2026
Definium Therapeutics, Inc. DFTX Health Care 1 Feb 26, 2026
Acadia Healthcare Company, Inc. ACHC Health Care 1 Feb 25, 2026

Representative quotes

…their CML therapy. However, now I do feel more comfortable to recommend it to my patients. If they are in trouble for inference or the travel for any other kinds of issue, even they have some other comorbidity, I strongly recommend them to go ahead to that kind…
Enliven Therapeutics, Inc. (ELVN), June 11, 2026. Read the full transcript →
FSGS population? Jason Coloma (Executives): Yes. I think it's -- I think there's been a lot of education as you're inferring about what FSGS is, and it's not a clinical diagnosis. It's a histological diagnosis by looking at a biopsy. And historically, kidney patients…
Maze Therapeutics, Inc. (MAZE), June 10, 2026. Read the full transcript →
…study run in that indication for a variety of historic reasons basically approval in the non-clear cell space is done somewhat by inference. Every drug that's approved in clear cell is also approved in non-clear cell the label reflects both despite the fact that…
Exelixis, Inc. (EXEL), June 9, 2026. Read the full transcript →
…really no question about that being a good enough signal. And I think that, that's kind of where we are. So by inference, I would say, it'd be very hard for hospitals not to adopt this therapy, be very hard for clinicians not to order…
Spectral Medical Inc. (EDT), June 8, 2026. Read the full transcript →

Frequently asked questions

What is AI Inference Demand and why are companies discussing it?

The compute spend that follows AI deployment — distinct from training. Critical for chips, networking and cloud economics.

Which company mentioned ai inference demand most in Health Care in the past year?

Exelixis, Inc. (EXEL) led with 6 calls referencing ai inference demand, most recently on June 9, 2026.

How can I track ai inference demand mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related technology themes

Last updated: June 19, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (inference, inference). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.